What is BPC-157 being investigated for
DOI 10.1001/jama.2021.3224 - run-in nausea 47% falling to 14% at maintenance
Starting Dose: 0.25 mg once daily Optimal Dose: 0.25 to 0.5 mg daily, with option to split into two doses Administration: Subcutaneous injection, abdomen preferred for systemic effects Timing: Morning injection, at least 2 hours away from Retatrutide Duration: 4 to 8 weeks cycles with 2 to 4 weeks off between What the Research Community Reports User experiences with BPC-157 alongside Retatrutide consistently highlight reduced GI symptoms
Tzang 2025 (18 RCTs): overweight/obesity regains +5.63 kg while type 2 diabetes regains +2.03 kg but rebounds harder on blood-sugar control (HbA1c +0.65 vs +0.25%)
Whether a combination preparation is clinically appropriate for you, and the resulting cost, depends on your evaluation
Each mL of sterile aqueous solution contains: Cyanocobalamin (B12)..........3000 mcg With sodium chloride 0.22% w/v, ammonium sulfate 0.1% w/v, citric acid 0.01% w/v, sodium citrate 0.008% w/v, and benzyl alcohol 1.0% v/v (preservative)